Re: Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
Crossref DOI link: https://doi.org/10.1007/s00417-017-3670-5
Published Online: 2017-04-08
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bahrami, Bobak
Hong, Thomas
Chang, Andrew
License valid from 2017-04-08